Articles, Analysis & Perspectives from SmartTRAK

Trauma: Top Trends to Watch in 2019 and Beyond

SmartTRAK identifies trends in the Trauma market that will shape the landscape in 2019.

By Natasha Weeks | Senior Analyst, Trauma and Extremities Fixation

2019 Spine Market Outlook: What to Expect this Year

SmartTRAK identifies trends to watch in Spine

By Julianne Burns | Senior Analyst, Spine

NASS 2018: New Technology in Computer-Assisted Surgery Takes Center Stage

Robotics and other enabling technologies created a buzz on the exhibit floor

By Elise Wolf | Senior Analyst, Computer Assisted Surgery

OrthoXel: Patient-Focused Orthopedic Trauma Devices

Ireland-based OrthoXel provides novel fracture fixation devices
using evidence-based implant design for the orthopedic trauma
market.

By Tim Jeavons | Director, European Orthopedic Content and Sales 

NASS 2018: State of the Spine Market

SmartTRAK analysts discuss “The State of the Spine Market: Implants, Robotics, and Spinal Cord Stimulation,” in a SmartTRAK-hosted panel discussion held prior to NASS 2018 in Los Angeles.

• Julianne Burns | Senior Analyst, Spine
• Anne Staylor | Managing Editor, Senior Director Advanced Technologies

US Ankle Replacement: What's New and What's Next?

SmartTRAK discusses the latest trends and future state of ankle replacement in an interview with Steven Haddad, MD, Senior Attending Physician, Illinois Bone and Joint Institute.

By Lisa Mahan | VP Content Orthopedics

Trends and Transactions in the Spine Market

Don Urbanowicz  interviews John Pracyk, MD of DePuy Synthes, Adam Wollowick, MD of Stryker Spine, and Bob Kinsella of Kinsella Group regarding trends and transactions in the spine market in a pre-NASS panel discussion entitled “From the Operating Room to the OEM.”

By Don Urbanowicz | Medical Device Consultant

Challenges and Opportunities for Wound Care in Assisted Living Facilities

Bluestone Physician Services’ Sarah Keenan, Chief Clinical Officer, and Jessie Waks, Director of Clinical Practice and Education, discuss challenges and opportunities related to wound care in assisted living facilities in an interview with SmartTRAK.

By Susan Paquette | VP, Wound

S&N Hopes to Solidify its Leadership Position in Wound Biologics

S&N plans to shore up its ailing Advanced Wound Bioactives business with the acquisition of Osiris Therapeutics but the deal may be in question as Osiris shareholders challenge the price.

By Susan Paquette | VP Wound

Growth Amid Debate: Open vs. Robotic Techniques for Inguinal Hernia Repair

SmartTRAK shines a light on issues and trends in robotic surgery and the market for inguinal hernia matrices.

By Doug Devens | Senior Analyst, Wound

Preventing Peripheral IV Failure: The Next Big Thing in Vascular Access Adjunct Products

Products that prevent peripheral IV failures could be the next big thing in the market for vascular access adjunct products, a market opportunity valued at more than $600MM in the US alone, according to SmartTRAK estimates.

By Susan Paquette | VP Wound

Wound Debridement: Robust Growth in a Dynamic Market

SmartTRAK forecasts robust growth for Wound Debridement Products, a dynamic market projected to reach $910MM by 2022E.

By Lennart Stadler | Senior Analyst, Wound

Top Trends to Watch in Hemostats and Sealants

SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market and the top trends to watch in the year ahead.

By Doug Devens | Senior Analyst, Wound

Market Opportunities and Trends at Desert Foot

SmartTRAK looks at market opportunities and trends in the treatment of diabetic foot ulcers at the recent Desert Foot Conference in Phoenix, AZ.

By Susan Paquette | VP, Wound

Advanced Therapies: An Interview with Robert Keller, PHD, Chief Science Officer of Axolotl Biologix

Stem cell “secretome” is the latest advancement in regenerative medicine. Will it become the heart of tissue regeneration? 

By Kim French | Senior Analyst, OrthoBio

Regenerative Medicine: Riding a Wave of Innovation

SmartTRAK highlights trends in regenerative medicine and profiles emerging companies focused on musculoskeletal regenerative therapies.

By Kim French | Senior Analyst, OrthoBio

Insera Therapeutics: Disruptive Digital Design for Stroke Aspiration

To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting,

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies

ISC 2019: Spotlight on Medtronic Neurovascular

SmartTRAK spotlights Medtronic Neurovascular in an interview with Andrew Cormack, VP Global Marketing, Neurovascular at Medtronic, at the International Stroke Conference in Honolulu.

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies

NANS 2019 Highlights and Key Takeaways

SmartTRAK reports from NANS 2019 and provides an update on the trials, trends, and technologies affecting the spinal cord stimulation market.

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies

Spinal Cord Stimulation: Top Trends to Watch in 2019 and Beyond

So what’s on the horizon? Here are SmartTRAK’s predictions for the top market and technology trends to watch.

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies

Strategies in Stroke Care: An Interview with Medtronic's Stacey Pugh

Medtronic’s Stacey Pugh discusses the Company’s new Riptide Aspiration System, new products in development, and growth strategies for the neurovascular business in a podcast interview from ISC 2018.

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies

The One to Beat: Nevro's Growth Strategies and Challenges in the Spinal Cord Stim Market

Nevro CEO Rami Elghandour discussed the Company’s success, its growth strategies, and some of the challenges of being the one
to beat in the spinal cord stimulation (SCS) market.

By Anne Staylor | Managing Editor, Senior Director Advanced Technologies